Cyclosporins
    6.
    发明授权
    Cyclosporins 有权
    环孢菌素

    公开(公告)号:US07538084B2

    公开(公告)日:2009-05-26

    申请号:US10802013

    申请日:2004-03-16

    IPC分类号: A61K38/00

    CPC分类号: C07K7/645

    摘要: The compounds of the present invention are represented by the chemical structure found in Formula I: Formula I where A is an amino acid of Formula II: or a pharmaceutically acceptable salt thereof, with R0, R1, B, C, D, E, F, G, H, I, J, and K defined herein.

    摘要翻译: 本发明的化合物由式I中所示的化学结构表示:

    公式I 其中A是式II的氨基酸: 或其药学上可接受的盐与本文定义的R0,R1,B,C,D,E,F,G,H,I,J和K.

      COMPOUNDS USEFUL AS ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
      9.
      发明申请
      COMPOUNDS USEFUL AS ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS 审中-公开
      化合物有效用作ALPHA7 NICOTINIC乙酰胆碱受体激动剂

      公开(公告)号:US20090181952A1

      公开(公告)日:2009-07-16

      申请号:US12353804

      申请日:2009-01-14

      IPC分类号: A61K31/5513 C07D403/12

      CPC分类号: C07D403/12

      摘要: The present invention provides compounds and compositions, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory systems.

      摘要翻译: 本发明提供了化合物和组合物以及使用它们调节α7烟碱乙酰胆碱受体和/或治疗各种疾病,疾病和病症中的任何一种的方法。 提供的化合物可以影响神经,精神和/或炎症系统。

      Aza-benzothiopyranoindazoles with antitumor activity
      10.
      发明授权
      Aza-benzothiopyranoindazoles with antitumor activity 失效
      具有抗肿瘤活性的氮杂 - 苯并噻喃并吲唑

      公开(公告)号:US06747039B2

      公开(公告)日:2004-06-08

      申请号:US10096421

      申请日:2002-03-12

      申请人: Simon N. Haydar

      发明人: Simon N. Haydar

      IPC分类号: A61K31435

      CPC分类号: C07D495/16

      摘要: The present invention relates to a group of aza-anthrapyrazole compounds having antitumor activity, and processes for their preparation. Compositions containing the aza-anthrapyrazole compounds and methods of treating tumors and cancer in mammals with the compounds of the present invention are also disclosed.

      摘要翻译: 本发明涉及一组具有抗肿瘤活性的氮杂蒽环唑类化合物及其制备方法。 还公开了含有氮杂蒽环唑化合物的组合物和用本发明化合物治疗哺乳动物肿瘤和癌症的方法。